MedPath

Pregnancy/Implantation Rates Using a Day 3 Score Versus Graduated Embryo Score Plus a Biochemical Marker (sHLA-G)

Not Applicable
Completed
Conditions
Infertility
Interventions
Drug: Human derived FSH
Registration Number
NCT00680238
Lead Sponsor
University of Stellenbosch
Brief Summary

Objective: To compare pregnancy rates and implantation rates when embryos are selected based on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.

Detailed Description

Comparing pregnancy rates and implantation rates when embryos are selected using the most common criteria for embryo selection on day 3 - the morphology-(number of blastomere, their shape and size and the percentage of fragmentation)vs a graduated embryo score accumulated over 72 hours and the expression of sHLA-G at 44-46 hours post fertilization.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
214
Inclusion Criteria
  • Self paying ART patients
Exclusion Criteria
  • Abnormal uterus
  • Specific Immunologic factors

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BHuman derived FSHEmbryos for transfer by first selecting any embryos that had a positive sHLA-G expression of OD = 190 ±6 and correlating such with the highest GES score available.
AHuman derived FSHEmbryo selection for transfer based on a Day 3 score only.
Primary Outcome Measures
NameTimeMethod
Pregnancy and implantation rates12 weeks
Secondary Outcome Measures
NameTimeMethod
Miscarriage rates9-11 day until βhCG
© Copyright 2025. All Rights Reserved by MedPath